-
公开(公告)号:KR1020080006895A
公开(公告)日:2008-01-17
申请号:KR1020060066207
申请日:2006-07-14
Applicant: (주)아모레퍼시픽
Abstract: A method of manufacturing green tea with a high content of Gallocatechin-3-gallate(GCG) by subjecting green tea leaf to steam treatment at high temperature and pressure to epimerize epigallocatechin-3-gallate(EGCG) after steaming or roasting treatment of the green tea leaf is provided to increase the content of GCG by a thermal conversion method. To make green tea with a high content of Gallocatechin-3-gallate, green tea leaf is treated with steam or roasted. In the process, the steam treatment is performed more than 2 times or roasting time is increased by more than 20%. The steam treatment or roasting is performed within 30min. After the steam treatment or roasting, steam sterilization treatment is additionally performed for 1 to 240min.
Abstract translation: 一种通过在高温高压下对绿茶叶进行蒸汽处理来制造具有高含量的Gallocatechin-3-没食子酸酯(GCG)的绿茶的方法,以在对绿色的蒸汽或焙烧处理后对表没食子儿茶素-3-没食子酸酯(EGCG)进行差向异构化 提供茶叶以通过热转化方法增加GCG的含量。 为了制备高含量的Gallocatechin-3-没食子酸酯的绿茶,用蒸汽或焙烤处理绿茶叶。 在此过程中,蒸汽处理时间超过2次,焙烧时间提高20%以上。 蒸汽处理或焙烧在30分钟内进行。 蒸汽处理或焙烧后,进行1〜240分钟的蒸汽灭菌处理。
-
公开(公告)号:KR1020080004906A
公开(公告)日:2008-01-10
申请号:KR1020060063824
申请日:2006-07-07
Applicant: (주)아모레퍼시픽
IPC: C07D311/04 , A61K31/353
CPC classification number: C07D311/58
Abstract: A method for preparing gallocatechin gallate is provided to increase the solubility of epigallocatechin gallate into a reaction solvent by using an organic solvent and increase the conversion rate into the gallocatechin gallate through epimerization by adjusting the pH, thereby capable of increasing the production amount of the gallocatechin gallate. A method for preparing gallocatechin gallate comprises a step of converting epigallocatechin gallate into the gallocatechin gallate by dissolving the epigallocatechin gallate in an alcohol-based solvent such as ethanol and methanol or a polyol based solvent such as butylene glycol, propylene glycol and polyethylene glycol and then heating the solution at a temperature of about 120 deg.C for 30-60 minutes.
Abstract translation: 提供了没食子儿茶素没食子酸酯的制备方法,以通过使用有机溶剂提高表没食子儿茶素没食子酸酯在反应溶剂中的溶解度,并通过调节pH提高通过差向异构化得到的儿茶素没食子酸酯的转化率,从而能够增加喜树碱的产生量 没食子酸酯。 没食子酸儿茶素没食子酸酯的制备方法包括将表没食子儿茶素没食子酸酯溶解在醇类溶剂如乙醇和甲醇或多元醇类溶剂如丁二醇,丙二醇和聚乙二醇中,将表没食子儿茶素没食子酸酯转化为喜树碱没食子酸酯,然后 在约120℃的温度下加热溶液30-60分钟。
-
公开(公告)号:KR101965595B1
公开(公告)日:2019-04-04
申请号:KR1020180102773
申请日:2018-08-30
Applicant: (주)아모레퍼시픽
IPC: A61K8/9789 , A61K8/9761 , A61Q7/00 , A23L33/105 , A61K36/48 , A61K36/14 , A61K36/484 , A61P17/14
-
公开(公告)号:KR101862172B1
公开(公告)日:2018-05-30
申请号:KR1020100084831
申请日:2010-08-31
Applicant: (주)아모레퍼시픽
IPC: A61K31/35 , A61K31/352 , A23L1/30
Abstract: 본발명은다이하이드로다이드제인을유효성분으로함유하는혈액순환개선용조성물에관한것으로, 보다상세하게는상기조성물은다이하이드로다이드제인을함유하여혈소판응집및 혈전생성을억제함으로써혈액순환개선효과가우수하고, 비만상태를개선시키며, 당뇨및 고질혈증등의치료또는예방에효과적인혈액순환개선용조성물에관한것이다.
-
公开(公告)号:KR101593618B1
公开(公告)日:2016-02-15
申请号:KR1020090045858
申请日:2009-05-26
Applicant: (주)아모레퍼시픽
IPC: A61K36/79 , A61K36/896 , A61K36/258
CPC classification number: A61K36/79 , A61K36/258 , A61K36/896 , A61K2300/00
Abstract: 본발명은사포닌의생체이용률증진인삼복합조성물에관한것이다. 또한, 오미자추출물및 맥문동추출물중 하나이상을포함하는추출물의용도로서, 사포닌생체이용률을증진시키는용도에관한것이다.
-
公开(公告)号:KR101427574B1
公开(公告)日:2014-08-07
申请号:KR1020140052032
申请日:2014-04-30
Applicant: (주)아모레퍼시픽
IPC: A61K8/97 , A61K36/258 , A61Q19/00 , A61P29/00
Abstract: 본 발명은 인삼 열매 추출물을 함유하는 항염증용 화장료 조성물에 관한 것으로서, 보다 상세하게는 인삼의 지상부 중에서 독특한 성분과 조성을 갖는 인삼 열매 추출물을 유효성분으로 함유함으로써 피지분비를 조절하며 항염증효과를 통한 여드름 및 피부 트러블 개선효과를 나타내는 조성물에 관한 것이다.
-
公开(公告)号:KR101415997B1
公开(公告)日:2014-07-09
申请号:KR1020140052030
申请日:2014-04-30
Applicant: (주)아모레퍼시픽
Abstract: 본 발명은 인삼 열매 추출물을 함유하는 피부 미백용 화장료 조성물에 관한 것으로서, 보다 상세하게는 인삼의 지상부 중에서 독특한 성분과 조성을 갖는 인삼 열매 추출물을 유효성분으로 함유함으로써 멜라닌생성을 억제하고 자외선에 의한 색소침착을 개선하는 효과를 통하여 피부 미백효과를 나타내는 조성물에 관한 것이다.
-
公开(公告)号:KR1020140065125A
公开(公告)日:2014-05-29
申请号:KR1020120132264
申请日:2012-11-21
Applicant: (주)아모레퍼시픽
IPC: A61K31/702 , A61K36/87 , A61K9/20 , A61K9/48
CPC classification number: A61K31/702 , A61K36/87 , A61K2300/00
Abstract: The present invention provides a composition containing chitooligosaccharide as an active ingredient for inhibiting activity of amylase and an anti-obesity drug comprising the same. According to the present invention, the composition can be used as an anti-obesity drug because of an excellent glycolysis-suppressing effect, by inhibiting the activity of amylase, by containing either chitooligosaccharide only or chitooligosaccharide and a grape seed extract as an active ingredient.
Abstract translation: 本发明提供了含有壳低聚糖作为抑制淀粉酶活性的活性成分的组合物和含有该组合物的抗肥胖药。 根据本发明,由于通过仅含有壳寡糖或壳低聚糖和葡萄籽提取物作为活性成分,通过抑制淀粉酶的活性而具有优异的糖酵解抑制效果,可以将该组合物用作抗肥胖药物。
-
公开(公告)号:KR1020140058486A
公开(公告)日:2014-05-14
申请号:KR1020140052030
申请日:2014-04-30
Applicant: (주)아모레퍼시픽
CPC classification number: A61K8/97 , A61K36/258 , A61K2236/17 , A61K2236/33 , A61Q19/02 , Y10S514/844
Abstract: The present invention relates to a cosmetic composition that contains ginseng fruit extract as an active ingredient in order to whiten the skin. More specifically, the present invention relates to a composition that contains, as an active ingredient, ginseng fruit extract that has particular components and composition from the above-ground part of a ginseng plant so as to represent a skin whitening effect by controlling the production of melanin and alleviating pigmentation caused by ultraviolet rays.
Abstract translation: 本发明涉及含有作为活性成分的人参水果提取物以使皮肤美白的化妆品组合物。 更具体地说,本发明涉及一种组合物,其含有作为活性成分的人参水果提取物,其具有来自人参植物的地上部分的特定成分和组成,以通过控制生产的方式代表皮肤美白效果 黑色素和减轻紫外线引起的色素沉着。
-
公开(公告)号:KR1020120020904A
公开(公告)日:2012-03-08
申请号:KR1020100084831
申请日:2010-08-31
Applicant: (주)아모레퍼시픽
IPC: A61K31/35 , A61K31/352 , A23L1/30
CPC classification number: A61K31/35 , A23L33/10 , A23V2002/00 , A61K31/352
Abstract: PURPOSE: A composition containing dihydrodaidzein for improving blood circulation is provided to suppress platelet coagulation and to treat and prevent diabetes, obesity, and hyperlipidemia. CONSTITUTION: A composition for improving blood circulation contains 0.01-50 wt% of dihydrodiadzein of chemical formula 1 as an active ingredient. The composition is a pharmaceutical composition for preventing or treating vascular diseases. The vascular diseases are obesity, diabetes, stroke, cerebral hemorrhage, hypertension, anemia, or hyperlipidemia. The composition is used in the form of a solution, emulsion, viscosity mixture, tablet, and powder.
Abstract translation: 目的:提供一种用于改善血液循环的含有二氢黄豆苷元的组合物以抑制血小板凝结,并治疗和预防糖尿病,肥胖症和高脂血症。 构成:用于改善血液循环的组合物含有0.01-50重量%的化学式1的二氢十氢化物作为活性成分。 该组合物是用于预防或治疗血管疾病的药物组合物。 血管疾病是肥胖,糖尿病,中风,脑出血,高血压,贫血或高脂血症。 该组合物以溶液,乳液,粘度混合物,片剂和粉末的形式使用。
-
-
-
-
-
-
-
-
-